RCKT
RocketยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RCKT Profile
Rocket Pharmaceuticals, Inc.
A leading late-stage, clinical biotech company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders
Biological Technology
07/07/1999
02/18/2015
NASDAQ Stock Exchange
299
12-31
Common stock
9 Cedarbrook Drive, Cranbury, NJ 08512
--
Rocket Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on July 7, 1999. The company is a fully integrated, late-stage biotechnology company focused on developing first-of-its-kind, unique and best-in-class gene therapies with direct targeted mechanisms of action and clear clinical endpoints for rare and destructive diseases.
